Definition of advanced age in HIV infection: looking for an age cut-off
- PMID: 22607516
- PMCID: PMC3423793
- DOI: 10.1089/AID.2011.0377
Definition of advanced age in HIV infection: looking for an age cut-off
Abstract
The age of 50 has been considered as a cut-off to discriminate older subjects within HIV-infected people according to the Centers for Disease Control and Prevention (CDC). However, the International AIDS Society (IAS) mentions 60 years of age and the Department of Health and Human Services (DHHS) makes no consideration. We aimed to establish an age cut-off that could differentiate response to highly active antiretroviral therapy (HAART) and, therefore, help to define advanced age in HIV-infected patients. CoRIS is an open, prospective, multicenter cohort of HIV adults naive to HAART at entry (January 2004 to October 2009). Survival, immunological response (IR) (CD4 increase of more than 100 cell/ml), and virological response (VR) (HIV RNA less than 50 copies/ml) were compared among 5-year age intervals at start of HAART using Cox proportional hazards models, stratified by hospital and adjusted for potential confounders. Among 5514 patients, 2726 began HAART. During follow-up, 2164 (79.4%) patients experienced an IR, 1686 (61.8%) a VR, and 54 (1.9%) died. Compared with patients aged <25 years at start of HAART, those aged 50-54, 55-59, 60-64, 65-59, and 70 or older were 32% (aHR: 0.68, 95% CI: 0.52-0.87), 29% (aHR: 0.71, 95% CI: 0.53-0.96), 34% (aHR: 0.66, 95% CI: 0.46-0.95), 39% (aHR: 0.61, 95% CI: 0.37-1.00), and 43% (aHR: 0.57, 95% CI: 0.31-1.04) less likely to experience an IR. The VR was similar across all age groups. Finally, patients aged 50-59 showed a 3-fold increase (aHR: 3.58; 95% CI: 1.07-11.99) in their risk of death compared to those aged <30 years. In HIV infection, patients aged ≥50 years have a poorer immunological response to HAART and a poorer survival. This age could be used to define medically advanced age in HIV-infected people.
Figures




Similar articles
-
Treatment outcome of HAART-treated patients in a resource-limited setting: the Belgrade Cohort Study.Biomed Pharmacother. 2014 Apr;68(3):391-5. doi: 10.1016/j.biopha.2014.01.001. Epub 2014 Jan 15. Biomed Pharmacother. 2014. PMID: 24486106 Clinical Trial.
-
Predictors of virological success and ensuing failure in HIV-positive patients starting highly active antiretroviral therapy in Europe: results from the EuroSIDA study.Arch Intern Med. 2000 Apr 24;160(8):1123-32. doi: 10.1001/archinte.160.8.1123. Arch Intern Med. 2000. PMID: 10789605
-
Disparities in antiretroviral treatment: a comparison of behaviorally HIV-infected youth and adults in the HIV Research Network.J Acquir Immune Defic Syndr. 2011 Sep 1;58(1):100-7. doi: 10.1097/QAI.0b013e31822327df. J Acquir Immune Defic Syndr. 2011. PMID: 21637114 Free PMC article.
-
[HIV infection and AIDS in advanced age. Epidemiological and clinical issues, and therapeutic and management problems].Infez Med. 2004 Sep;12(3):152-73. Infez Med. 2004. PMID: 15711129 Review. Italian.
-
Human immunodeficiency virus in an aging population, a complication of success.J Am Geriatr Soc. 2009 Nov;57(11):2129-38. doi: 10.1111/j.1532-5415.2009.02494.x. Epub 2009 Sep 28. J Am Geriatr Soc. 2009. PMID: 19793157 Review.
Cited by
-
Unmet basic needs negatively affect health-related quality of life in people aging with HIV: results from the Positive Spaces, Healthy Places study.BMC Public Health. 2018 May 21;18(1):644. doi: 10.1186/s12889-018-5391-z. BMC Public Health. 2018. PMID: 29783965 Free PMC article.
-
Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel.JAMA. 2020 Oct 27;324(16):1651-1669. doi: 10.1001/jama.2020.17025. JAMA. 2020. PMID: 33052386 Free PMC article.
-
Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults.Brain Res. 2019 Nov 15;1723:146398. doi: 10.1016/j.brainres.2019.146398. Epub 2019 Aug 21. Brain Res. 2019. PMID: 31442412 Free PMC article. Review.
-
Low incidence of advanced neurological burden but high incidence of age-related conditions that are dementia risk factors in aging people living with HIV: a data-linkage 10-year follow-up study.J Neurovirol. 2023 Apr;29(2):141-155. doi: 10.1007/s13365-022-01104-0. Epub 2022 Dec 12. J Neurovirol. 2023. PMID: 36508059 Free PMC article.
-
Preventing Cognitive Decline in Older Latino Adults With HIV Through a Culturally Tailored Health Promotion Intervention: Protocol for a Single-Arm Pilot Trial.JMIR Res Protoc. 2024 Aug 12;13:e55507. doi: 10.2196/55507. JMIR Res Protoc. 2024. PMID: 39133532 Free PMC article.
References
-
- Bhavan KP. Kampalath VN. Overton ET. The aging of the HIV epidemic. Curr HIV/AIDS Rep. 2008;5:150–158. - PubMed
-
- Deeks SG. Phillips AN. HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. BMJ. 2009;338:288–292. - PubMed
-
- Centers for Disease Control and Prevention: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;41:1–19. - PubMed
-
- Knobel H. Guelar A. Valldecillo G. Carmona A. González A. López-Colomés JL, et al. Response to highly active antiretroviral therapy in HIV-1 infected patients aged 60 years or older after 24 months of follow up. AIDS. 2001;15:1591–1593. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials